Resource Center
Emmes possesses deep experience in clinical research which we leverage on behalf of our clients. It is through our collaborative efforts with you that Emmes has conducted over 2,150 clinical trials and published 2,300+ peer-reviewed articles.
In this section of our site, we share our experience and publications with you as a tribute to our ongoing collaboration.
Resources
Publications
First Safety & Immunogenicity Data from a FIH, Placebo-controlled, Dose escalation Trial of a Recombinant Vesicular Stomatitis Virus based Lassa Fever Vaccine in Healthy Adults
11/2023
Malkin E,, Baden, L,, Kieh M,, Fitz Patrick D, , Diemert D,, Mutua G,, Philiponis V,, Zaric M,, Hunt D,, Barin B,, Engelbrecht M,, Malherbe M,, Walker K,, Lehrman J,, Fast P,, Parks C,, Gupta SB
Pharmacokinetics, Safety, and Tolerability of Oxfendazole in Healthy Adults in an Open-Label Phase 1 Multiple Ascending Dose and Food Effect Study
10/2020
Bach, T., Galbiati, S., Kennedy, J. K., Deye, G., Nomicos, E. Y. H., Codd, E. E., Garcia, H. H., Horton, J., Gilman, R. H., Gonzalez, A. E., Winokur, P., An, G.
Safety and pharmacokinetics of antifungal agent VT-1598 and its primary metabolite, VT-11134, in healthy adult subjects: phase 1, first-in-Human, randomized, double-blind, placebo-controlled study of single-ascending oral doses of VT-1598
04/2024
Gu, K., Spitz, R., Hammett, E., Jaunarajs, A., Ghazaryan, V., Garvey, E. P., Degenhardt, T.
A Phase 1, Double-blinded, Placebo-Controlled Clinical Trial to Evaluate the Safety and Immunogenicity of HEV-239 (Hecolin(R)) Vaccine in Healthy US Adults
03/2024
Kao, C. M., Rostad, C. A., Nolan, L. E., Peters, E., Kleinhenz, J., Sherman, J. D., Tippett, A., Shih, J. W. K., Yildirim, I., Agbakoba, V., Beresnev, T. , Ballou, C., Kamidani, S., Karmali, V., Natrajan, M., Scherer, E. M., Rouphael, N., Anderson, E. J.
The safety and immunogenicity of a bivalent conjugate vaccine against Salmonella enterica Typhi and Paratyphi A in healthy Indian adults: a phase 1, randomised, active-controlled, double-blind trial
04/2024
Kulkarni, P. S., Potey, A. V., Bharati, S., Kunhihitlu, A., Narasimha, B., Yallapa, S., Dharmadhikari, A., Gavade, V., Kamat, C. D., Mallya, A., Sarma, A. D., Goel, S., Pisal, S. S., Poonawalla, C. S., Venkatesan, R., Jones, E., Flaxman, A., Kim, Y. C. , Pollard, A. J., T. C. V. Study Group
A Phase 2 Clinical Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of Different Prime-Boost Vaccination Schedules of 2013 and 2017 A(H7N9) Inactivated Influenza Virus Vaccines Administered with and without AS03 Adjuvant in Healthy US Adul
03/2024
Rostad, C. A., Atmar, R. L., Walter, E. B., Frey, S., Meier, J. L., Sherman, A. C., Lai, L., Tsong, R., Kao, C. M., Raabe, V., El Sahly, H. M., Keitel, W. A., Whitaker, J. A., Smith, M. J., Schmader, K. E., Swamy, G. K., Abate, G., Winokur, P, Buchanan, W., Cross, K., Wegel, A., Xu, Y., Yildirim, I., Kamidani, S., Rouphael, N., Roberts, P. C., Mulligan, M. J., Anderson, E. J.
Prevalence of obesity for opioid- and stimulant-dependent participants in substance use treatment clinical trials
08/2018
Hu, L., Matthews, A., Shmueli-Blumberg, D., Killeen, T. K., Tai, B., VanVeldhuisen, P.
The process and challenges of language translation and cultural adaptation of study instruments: a case study from the NIDA CTN CHOICES-2 trial
08/2021
Collins, J. A., Lewin, S., Shmueli-Blumberg, D., Hoffman, K. A., Terashima, J. P., Korthuis, P. T., Horigian, V. E.
Comparing Web-Based Platforms for Promoting HIV Self-Testing and Pre-Exposure Prophylaxis Uptake in High-Risk Men Who Have Sex With Men: Protocol for a Longitudinal Cohort Study
10/2020
Lemley, S. M., Klausner, J. D., Young, S. D., Stafylis, C., Mulatya, C., Oden, N., Xie, H., Revoredo, L., Shmueli-Blumberg, D., Hichborn, E., McKelle, E., Moran, L., Jacobs, P., Marsch, L. A.